Established and Future Promising Fertility Preservation Options in Adolescence and Adults


fertility preservation
cancer treatment
gonad tissue cryopreservation

How to Cite

Yazdekhasti, H., & Rajabi, Z. (2017). Established and Future Promising Fertility Preservation Options in Adolescence and Adults. Internal Medicine and Medical Investigation Journal, 3(1), 1-7.


Over the past decades, due to a high number of cancer survivors, the demands for fertility preservation have been raised dramatically, and this might come from recent progress in the cancer prognosis and diagnosis procedures. For those who are involved in cancer diseases, there are multiple options regarding their fertility preservation which can be selected based on patient’s age, the risk of gonadal involvement, the time available and the type of cancer with different advantages and disadvantages. Among all possible options, embryo cryopreservation for females and semen freezing for males are the most applicable method, however other options such as gonadal tissue cryopreservation, and oocyte cryopreservation are other promising options which would be considered if the partner was not available. As conclusion, this is noteworthy that women with cancer must benefit from adequate consultations regarding their possible fertility preservation options and immediate correct consultations definitely can help families to make their mind to choose best available options.


Boivin, J., Bunting, L., Collins, J.A., and Nygren, K.G., International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Human reproduction, 2007. 22(6): p. 1506-1512.

Stephen, E.H. and Chandra, A., Declining estimates of infertility in the United States: 1982–2002. Fertility and sterility, 2006. 86(3): p. 516-523.

Mascarenhas, M.N., Flaxman, S.R., Boerma, T., Vanderpoel, S., and Stevens, G.A., National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS medicine, 2012. 9(12): p. e1001356.

Apperley, J. and Reddy, N., Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy. Blood reviews, 1995. 9(2): p. 93-116.

Meirow, D. and Nugent, D., The effects of radiotherapy and chemotherapy on female reproduction. Human reproduction update, 2001. 7(6): p. 535-543.

Ziaee, M., Saádatjoo, A., Mohamadpour, M., and Namaei, M.H., Induced HBs antigenemia in healthy adults after immunization with two different hepatitis B recombinant vaccines. Hepatitis monthly, 2010. 10(4): p. 298.

Asgari, H.R., Akbari, M., Yazdekhasti, H., Rajabi, Z., Navid, S., et al., Comparison of Human Amniotic, Chorionic, and Umbilical Cord Multipotent Mesenchymal Stem Cells Regarding Their Capacity for Differentiation Toward Female Germ Cells. Cellular Reprogramming (Formerly" Cloning and Stem Cells"), 2017. 19(1): p. 44-53.

Yazdekhasti, H., Rajabi, Z., and Akrami, S.M., Ethical issues associated with advanced paternal age and genetic disorders in their offspring. Arvand Journal of Health and Medical Sciences, 2017.

Aliakbari, F., Sedighi Gilani, M.A., Yazdekhasti, H., Koruji, M., Asgari, H.R., et al., Effects of antioxidants, catalase and α-tocopherol on cell viability and oxidative stress variables in frozen-thawed mice spermatogonial stem cells. Artificial cells, nanomedicine, and biotechnology, 2016: p. 1-6.

Parvari, S., Yazdekhasti, H., Rajabi, Z., Gerayeli Malek, V., Rastegar, T., et al., Differentiation of mouse ovarian stem cells toward oocyte-like structure by coculture with granulosa cells. Cellular Reprogramming (Formerly" Cloning and Stem Cells"), 2016. 18(6): p. 419-428.

Aliakbari, F., Yazdekhasti, H., Abbasi, M., Hajian Monfared, M., and Baazm, M., Advances in cryopreservation of spermatogonial stem cells and restoration of male fertility. Microscopy research and technique, 2016. 79(2): p. 122-129.

Aliakbari, F., Gilani, M.A.S., Amidi, F., Baazm, M., Korouji, M., et al., Improving the efficacy of cryopreservation of spermatogonia stem cells by antioxidant supplements. Cellular Reprogramming (Formerly" Cloning and Stem Cells"), 2016. 18(2): p. 87-95.

Parvari, S., Abbasi, M., Abbasi, N., Malek, V.G., Amidi, F., et al., Stem cell isolation by a morphology-based selection method in postnatal mouse ovary. Archives of medical science: AMS, 2015. 11(3): p. 670.

Asgari, H.R., Yazdekhasti, H., Rajabi, Z., and Abbasi, M., Comparison of human amniotic, chorionic and umbilical cord Multipotent Mesenchymal Stem Cells regarding their capacity for differentiation toward female germ cells. cellular Reprogramming (Formerly" Cloning and Stem Cells"): p. In Press.

Yazdekhasti, H., Hosseini, M.A., Rajabi, Z., Parvari, S., Salehnia, M., et al., Improved Isolation, Proliferation, and Differentiation Capacity of Mouse Ovarian Putative Stem Cells. Cellular Reprogramming (Formerly" Cloning and Stem Cells"), 2017. 19(2): p. 132-144.

Hakak, M.A., Amiri, H., Mohammadpour, M., Vosough, I., Razavi, B., et al., Diagnostic and therapeutic role of long term Video-EEG monitoring in patients with psychogenic non-epileptic attacks. Razavi Int J Med, 2013. 1(November (1)): p. 17-21.

Meirow, D. and Schenker, J., Infertility: Cancer and male infertility. Human Reproduction, 1995. 10(8): p. 2017-2022.

Hallak, J., Kolettis, P.N., Sekhon, V.S., Thomas, A.J., and Agarwal, A., Sperm cryopreservation in patients with testicular cancer. Urology, 1999. 54(5): p. 894-899.

Schneider, M., Chau, L., Mohamadpour, M., Stephens, N., Arya, K., et al., EEG asymmetry and BIS/BAS among healthy adolescents. Biological psychology, 2016. 120: p. 142-148.

Kehinde, B.A., Abolhassani, F., Yazdekhasti, H., Abbasi, N., Heydari, L., et al., The effects of unilateral varicose ovarian vein on antioxidant capacity and oocyte quality in rat ovary. Iranian journal of basic medical sciences, 2016. 19(8): p. 863.

Socié, G., Salooja, N., Cohen, A., Rovelli, A., Carreras, E., et al., Nonmalignant late effects after allogeneic stem cell transplantation. Blood, 2003. 101(9): p. 3373-3385.

Kashani, I.R., Rajabi, Z., Akbari, M., Hassanzadeh, G., Mohseni, A., et al., Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis. Experimental brain research, 2014. 232(9): p. 2835-2846.

Gidoni, Y., Holzer, H., Tulandi, T., and Tan, S.L., Fertility preservation in patients with non-oncological conditions. Reproductive biomedicine online, 2008. 16(6): p. 792-800.

De Moor, J.S., Mariotto, A.B., Parry, C., Alfano, C.M., Padgett, L., et al., Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiology and Prevention Biomarkers, 2013. 22(4): p. 561-570.

Council, N.R., Childhood cancer survivorship: improving care and quality of life. 2003: National Academies Press.

Postovsky, S., Lightman, A., Aminpour, D., Elhasid, R., Peretz, M., et al., Sperm cryopreservation in adolescents with newly diagnosed cancer. Pediatric Blood & Cancer, 2003. 40(6): p. 355-359.

Aliakbari, F., Sedighi Gilani, M.A., Yazdekhasti, H., Koruji, M., Asgari, H.R., et al., Effects of antioxidants, catalase and α-tocopherol on cell viability and oxidative stress variables in frozen-thawed mice spermatogonial stem cells. Artificial cells, nanomedicine, and biotechnology, 2017. 45(1): p. 63-68.

Brinster, R.L., Male germline stem cells: from mice to men. Science, 2007. 316(5823): p. 404-405.

Brinster, R.L. and Avarbock, M.R., Germline transmission of donor haplotype following spermatogonial transplantation. Proceedings of the National Academy of Sciences, 1994. 91(24): p. 11303-11307.

Aslam, I., Fishel, S., Moore, H., Dowell, K., and Thornton, S., Fertility preservation of boys undergoing anti-cancer therapy: a review of the existing situation and prospects for the future: Opinion. Human Reproduction, 2000. 15(10): p. 2154-2159.

Grischenko, V., Dunaevskaya, A., and Babenko, V., Cryopreservation of human sperm using rapid cooling rates. Cryoletters, 2003. 24(2): p. 67-76.

Meseguer, M., Garrido, N., Remohi, J., Pellicer, A., Simon, C., et al., Testicular sperm extraction (TESE) and ICSI in patients with permanent azoospermia after chemotherapy*. Human reproduction, 2003. 18(6).

Lee, S.J., Schover, L.R., Partridge, A.H., Patrizio, P., Wallace, W.H., et al., American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. Journal of clinical oncology, 2006. 24(18): p. 2917-2931.

Blumenfeld, Z., Avivi, I., Linn, S., Epelbaum, R., Ben-Shahar, M., et al., Endocrinology: Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. Human Reproduction, 1996. 11(8): p. 1620-1626.

Jahnukainen, K., Ehmcke, J., Hou, M., and Schlatt, S., Testicular function and fertility preservation in male cancer patients. Best practice & research Clinical endocrinology & metabolism, 2011. 25(2): p. 287-302.

Jensen, A.K., Macklon, K.T., Fedder, J., Ernst, E., Humaidan, P., et al., 86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen-thawed ovarian tissue: focus on birth and perinatal outcome in 40 of these children. Journal of assisted reproduction and genetics, 2017. 34(3): p. 325-336.

Loren, A.W., Mangu, P.B., Beck, L.N., Brennan, L., Magdalinski, A.J., et al., Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. Journal of Clinical Oncology, 2013. 31(19): p. 2500-2510.

Oktay, K., Nugent, D., Newton, H., Salha, O., Chatterjee, P., et al., Isolation and characterization of primordial follicles from fresh and cryopreserved human ovarian tissue. Fertility and sterility, 1997. 67(3): p. 481-486.

Sonmezer, M. and Oktay, K., Fertility preservation in female patients. Human reproduction update, 2004. 10(3): p. 251-266.

Leporrier, M., Von Theobald, P., Roffe, J.L., and Muller, G., A new technique to protect ovarian function before pelvic irradiation: heterotopic ovarian autotransplantation. Cancer, 1987. 60(9): p. 2201-2204.

Donnez, J. and Kim, S.S., Principles and practice of fertility preservation. 2011: Cambridge university press.

Johnson, E.K., Finlayson, C., Rowell, E.E., Gosiengfiao, Y., Pavone, M.E., et al., Fertility preservation for pediatric patients: current state and future possibilities. The Journal of Urology, 2017. 198(1): p. 186-194.

Bedoschi, G. and Oktay, K., Current approach to fertility preservation by embryo cryopreservation. Fertility and sterility, 2013. 99(6): p. 1496-1502.

Cakmak, H. and Rosen, M.P., Ovarian stimulation in cancer patients. Fertility and sterility, 2013. 99(6): p. 1476-1484.

Cobo, A. and Diaz, C., Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertility and sterility, 2011. 96(2): p. 277-285.

Cobo, A., Meseguer, M., Remohí, J., and Pellicer, A., Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Human reproduction, 2010. 25(9): p. 2239-2246.

Roque, M., Lattes, K., Serra, S., Sola, I., Geber, S., et al., Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis. Fertility and sterility, 2013. 99(1): p. 156-162.

Donnez, J., Dolmans, M.-M., Pellicer, A., Diaz-Garcia, C., Serrano, M.S., et al., Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertility and sterility, 2013. 99(6): p. 1503-1513.

Wu, J., Zhang, L., and Wang, X., In vitro maturation, fertilization and embryo development after ultrarapid freezing of immature human oocytes. Reproduction, 2001. 121(3): p. 389-393.

Toth, T.L., Lanzendorf, S.E., Sandow, B.A., Veeck, L.L., Hassen, W.A., et al., Cryopreservation of human prophase I oocytes collected from unstimulated follicles. Fertility and sterility, 1994. 61(6): p. 1077-1082.

De Vos, M., Smitz, J., and Woodruff, T.K., Fertility preservation in women with cancer. The Lancet, 2014. 384(9950): p. 1302-1310.

Smitz, J., Dolmans, M.-M., Donnez, J., Fortune, J., Hovatta, O., et al., Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation. Human reproduction update, 2010. 16(4): p. 395-414.

Nugent, D., Meirow, D., Brook, P., Aubard, Y., and Gosden, R., Transplantation in reproductive medicine: previous experience, present knowledge and future prospects. Human Reproduction Update, 1997. 3(3): p. 267-280.

Kim, S.S., Battaglia, D.E., and Soules, M.R., The future of human ovarian cryopreservation and transplantation: fertility and beyond. Fertility and sterility, 2001. 75(6): p. 1049-1056.

Dolmans, M.-M., Donnez, J., Camboni, A., Demylle, D., Amorim, C., et al., IVF outcome in patients with orthotopically transplanted ovarian tissue. Human reproduction, 2009. 24(11): p. 2778-2787.

Telfer, E.E. and Zelinski, M.B., Ovarian follicle culture: advances and challenges for human and nonhuman primates. Fertility and sterility, 2013. 99(6): p. 1523-1533.

Amorim, C.A., Van Langendonckt, A., David, A., Dolmans, M.-M., and Donnez, J., Survival of human pre-antral follicles after cryopreservation of ovarian tissue, follicular isolation and in vitro culture in a calcium alginate matrix. Human Reproduction, 2008. 24(1): p. 92-99.

Demeestere, I., Simon, P., Emiliani, S., Delbaere, A., and Englert, Y., Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease. The oncologist, 2007. 12(12): p. 1437-1442.

Medicine, P.C.o.t.A.S.f.R., Ovarian tissue cryopreservation: a committee opinion. Fertility and sterility, 2014. 101(5): p. 1237-1243.

Williams, R.S., Littell, R.D., and Mendenhall, N.P., Laparoscopic oophoropexy and ovarian function in the treatment of Hodgkin disease. Cancer, 1999. 86(10): p. 2138-2142.

Thomas, P., Winstanly, D., Peckham, M., Austin, D., Murray, M., et al., Reproductive and endocrine function in patients with Hodgkin's disease: effects of oophoropexy and irradiation. British journal of cancer, 1976. 33(2): p. 226.

Pacheco, B.P., Ribas, J.M., Milone, G., Fernandez, I., Kvicala, R., et al., Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report. Gynecologic oncology, 2001. 81(3): p. 391-397.

Blumenfeld, Z., Avivi, I., Ritter, M., and Rowe, J., Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women. Journal of the Society for Gynecologic Investigation, 1999. 6(5): p. 229-239.

Gosden, R., Wade, J., Fraser, H., Sandow, J., and Faddy, M., Impact of congenital or experimental hypogonadotrophism on the radiation sensitivity of the mouse ovary. Human reproduction, 1997. 12(11): p. 2483-2488.

Otala, M., Suomalainen, L., Pentikäinen, M.O., Kovanen, P., Tenhunen, M., et al., Protection from Radiation-Induced Male Germ Cell Loss by Sphingosine-1-Phosphate 1. Biology of reproduction, 2004. 70(3): p. 759-767.

Carmely, A., Meirow, D., Peretz, A., Albeck, M., Bartoov, B., et al., Protective effect of the immunomodulator AS101 against cyclophosphamide-induced testicular damage in mice. Human reproduction, 2009. 24(6): p. 1322-1329.

Gonfloni, S., Di Tella, L., Caldarola, S., Cannata, S.M., Klinger, F.G., et al., Inhibition of the c-Abl–TAp63 pathway protects mouse oocytes from chemotherapy-induced death. Nature medicine, 2009. 15(10): p. 1179-1185.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.